In summary, the HMGCS2-mediated regulation of ketogenesis represented an important mechanism underlying the attenuation of liver disease progression in NASH-T2DM comorbidity. This evidence concerns the gene HMGCS2 and metabolic dysfunction-associated steatohepatitis.